ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

NCAB Member Seeks Broder’s Resignation, Gets No support

June 3, 1994

In Brief: Magnuson Subcommittee Increases NCI, NIH Budgets Despite Trimming Labor-HEW Bill By $250 Million

August 23, 1974

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

1985 International Cancer Congress to Be In Budapest

September 24, 1982

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Program Announcements Non-Invasive Detection Of Lung Cancer

April 15, 1983